Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study (Q42668576)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2014

Language	Label	Description	Also known as
English	Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study	scientific article published on October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

amyotrophic lateral sclerosis

0 references

author name string

Hyun Young Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Heejaung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ki-Wook Oh

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seong-Il Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seong-Ho Koh

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Wonki Baik

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Min Young Noh

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kyung Suk Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seung Hyun Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2724-2731

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cells for the treatment of neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

In vitro evidence for impaired neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis (hSOD1(G93A)).

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Intricate interplay between astrocytes and motor neurons in ALS.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Functional outcome measures as clinical trial endpoints in ALS.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Bone Marrow-Derived Stromal Cells from Amyotrophic Lateral Sclerosis Patients Have Diminished Stem Cell Capacity

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.1770

21 January 2018

Identifiers

10.1002/STEM.1770

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42668576&oldid=1965013760"